MedPath

administration of Ondansetron before spinal anaesthesia for prevention of hypotension in elective caesarean section.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/02/031305
Lead Sponsor
Vijayanagar institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Primiparous and multiparous parturient women with a single foetus posted for Elective caesarean section

2)37â??42 weeks of gestation

3)ASA grade II

4)Normal foetal profile

Exclusion Criteria

1)Contraindication for or refusal of spinal anaesthesia

2)Hypertension (SBP >140 mm Hg or DBP >90 mm Hg), Chronic or gestational hypertension or preeclampsia

3)Cardiovascular and/or cerebrovascular diseases

4)Diabetes mellitus

5)Administration of 5-hydroxytryptamine (5-HT3) reuptake inhibitors or drugs for the treatment of migraines

6)Treatment with antiemetics (including 5 HT3 blockers) within 72 h of surgery

7)Hypersensitivity to ondansetron, fentanyl, or bupivacaine

8)Obesity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of hypotensionTimepoint: after spinal anaesthesia throughout the procedure.
Secondary Outcome Measures
NameTimeMethod
1)Need of vasopressors <br/ ><br> 2)intraoperative nausea and vomiting (INOV) <br/ ><br>3)neonatal outcomes in terms of APGAR score <br/ ><br>Timepoint: after spinal anaesthesia throughout the procedure
© Copyright 2025. All Rights Reserved by MedPath